Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | MMP8 | P22894 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4663375 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL1928731 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4665144 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL3339295 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL3777627 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4259397 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL436730 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL4663096 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL440049 | 1.00 | LMNA (0.36) | LMNATHRBCA1CA2MMP1 | |
| SCHEMBL3782809 | 0.97 | THRB (0.32) | LMNATHRBKDM4ETSHRTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110556509-A | Method for performing surface protection and passivation treatment on metallic lithium cathode by using fluorine-containing organic matter, product and application | NANJING UNIVERSITY OF TECHNOLOGY | 2019-12-10 | — | — | CN | claimed |
| CN-115989005-A | Polyurethane composite sheet, method for producing a composite sheet and use thereof for producing medical implants | 帝斯曼知识产权资产管理有限公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115667344-A | Polymer composition and method for manufacturing medical implant | 马斯特里赫特大学医学中心 | 2023-01-31 | — | — | CN | disclosed |
| CN-115634312-A | Medical implant assembly comprising composite biological textile and method of manufacture | 帝斯曼知识产权资产管理有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-113518633-B | Medical implant assembly comprising composite biological textile and method of manufacture | 帝斯曼知识产权资产管理有限公司 | 2022-11-18 | — | — | CN | disclosed |
| CN-113490516-B | Method for preparing composite biological textile and medical implant comprising composite biological textile | 帝斯曼知识产权资产管理有限公司 | 2022-11-08 | — | — | CN | disclosed |
| CN-113518634-B | Radiopaque medical assemblies and devices | 帝斯曼知识产权资产管理有限公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-111148776-B | Synthetic film compositions comprising polyurethane blends | 帝斯曼知识产权资产管理有限公司 | 2022-06-03 | — | — | CN | disclosed |
| CN-113518634-A | Radiopaque medical assemblies and devices | 帝斯曼知识产权资产管理有限公司 | 2021-10-19 | — | — | CN | disclosed |
| CN-113518633-A | Medical implant assembly comprising composite biological textile and method of manufacture | 帝斯曼知识产权资产管理有限公司 | 2021-10-19 | — | — | CN | disclosed |
| CN-112538025-A | Preparation method of fluorine-containing compound for hydrophobic surface treatment agent | 湖北福力德鞋业有限责任公司 | 2021-03-23 | — | — | CN | disclosed |
| CN-111971330-A | Modified porous polyolefin film and production method thereof | 帝斯曼知识产权资产管理有限公司 | 2020-11-20 | — | — | CN | disclosed |
| CN-111278358-A | Synthetic membrane compositions comprising fluorinated polyurethanes | 帝斯曼知识产权资产管理有限公司 | 2020-06-12 | — | — | CN | disclosed |
| CN-111278357-A | Synthetic membrane compositions comprising polyurethane and polyoxazoline | 帝斯曼知识产权资产管理有限公司 | 2020-06-12 | — | — | CN | disclosed |
| CN-111148776-A | Synthetic film compositions comprising polyurethane blends | 帝斯曼知识产权资产管理有限公司 | 2020-05-12 | — | — | CN | disclosed |
| CN-110556509-A | Method for performing surface protection and passivation treatment on metallic lithium cathode by using fluorine-containing organic matter, product and application | NANJING UNIVERSITY OF TECHNOLOGY | 2019-12-10 | — | — | CN | disclosed |
| US-20080153982-A1 | Vinyl-Thiocarbonate and Polyol Containing Block Copolymers | LUBRIZOL ADVANCED MATERIALS, INC. | 2008-06-26 | — | — | US | disclosed |
| US-20060079701-A1 | Method for preparing perfluorocarbon-substituted methanols | EXFLUOR RESEARCH CORPORATION (US) | 2006-04-13 | — | — | US | disclosed |
| US-6380432-B2 | AROMATIC DIAMINES USEFUL IN PREPARING POLYIMIDES | ELSICON INC. | 2002-04-30 | — | — | US | disclosed |
| US-6194039-B1 | POLYIMIDES, POLYAMIC ACIDS | ELSICON, INC. | 2001-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060079701-A1 | Method for preparing perfluorocarbon-substituted methanols | PFAS, DECR2, DHCR7 | LMNA 739/4885THRB 3811/4885CA1 2341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.